Hudson Reddon, PhD is a Research Scientist at the BCCSU and Assistant Professor at the UBC Faculty of Medicine.

At the BCCSU, Dr. Reddon’s research focus is to conduct innovative longitudinal research to elucidate the risks, as well as the potential benefits, of evolving cannabis use/access patterns among people at highest risk of overdose and other substance-related harms during the fentanyl era. He is also interested in investigating the predictors of HIV disease progression and engagement with HIV care among marginalized and medically underserved people who use drugs.

Dr. Reddon has an established track record of attracting research funds as a principal investigator or co-applicant (Canadian Institutes of Health Research, Public Health Agency of Canada) and has published numerous peer-reviewed scientific papers in high impact academic journals including ­Clinical Infectious Diseases, American Journal of Public Health and Lancet HIV. Dr. Reddon has a keen interest in teaching and completed a Bachelors of Education degree at the University of Toronto. He has been involved in the design and delivery of curriculum among undergraduate and graduate students in the areas of health equity and chronic disease management at UBC and Trinity College Dublin. Dr. Reddon holds a Michael Smith Health Research BC Scholar Award and received his graduate training at McMaster University in Health Research Methodology and Clinical Epidemiology. He is an active member of the Canadian Society of Addiction Medicine, the International Cannabinoid Research Society and the Canadian HIV Trials Network.